Pyridine substituted antiviral heterocyclic compound and pharmaceutical composition thereof
PK144825APending Publication Date: 2026-07-09ENANTA PHARM INC
Patent Information
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- ENANTA PHARM INC
- Filing Date
- 2023-04-07
- Publication Date
- 2026-07-09
Abstract
The present invention discloses compound of Formula (I), and ester, or prodrug thereof: which inhibit Human Respiratory Syncytial Virus (HRSV) or Human Metapneumovirus (HMPV). The present invention further relates to pharmaceutical composition comprising the aforementioned compound for administration to a subject suffering from HRSV or HMPV infection.
Need to check novelty before this filing date? Find Prior Art